104 related articles for article (PubMed ID: 27777246)
21. In vitro evaluation of major in vivo drug metabolic pathways using primary human hepatocytes and HepaRG cells in suspension and a dynamic three-dimensional bioreactor system.
Darnell M; Ulvestad M; Ellis E; Weidolf L; Andersson TB
J Pharmacol Exp Ther; 2012 Oct; 343(1):134-44. PubMed ID: 22776955
[TBL] [Abstract][Full Text] [Related]
22. Automated triplexed hepatocyte-based viability and CYP1A and -3A induction assays.
Larson B; Moeller T; Banks P; Cali JJ
J Biomol Screen; 2011 Sep; 16(8):895-902. PubMed ID: 21693767
[TBL] [Abstract][Full Text] [Related]
23. Long-term chronic toxicity testing using human pluripotent stem cell-derived hepatocytes.
Holmgren G; Sjögren AK; Barragan I; Sabirsh A; Sartipy P; Synnergren J; Björquist P; Ingelman-Sundberg M; Andersson TB; Edsbagge J
Drug Metab Dispos; 2014 Sep; 42(9):1401-6. PubMed ID: 24980256
[TBL] [Abstract][Full Text] [Related]
24. HepaRG human hepatic cell line utility as a surrogate for primary human hepatocytes in drug metabolism assessment in vitro.
Lübberstedt M; Müller-Vieira U; Mayer M; Biemel KM; Knöspel F; Knobeloch D; Nüssler AK; Gerlach JC; Zeilinger K
J Pharmacol Toxicol Methods; 2011; 63(1):59-68. PubMed ID: 20460162
[TBL] [Abstract][Full Text] [Related]
25. Prediction of drug-drug interactions from in vitro induction data: application of the relative induction score approach using cryopreserved human hepatocytes.
Fahmi OA; Boldt S; Kish M; Obach RS; Tremaine LM
Drug Metab Dispos; 2008 Sep; 36(9):1971-4. PubMed ID: 18519654
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of 23 lots of commercially available cryopreserved hepatocytes for induction assays of human cytochromes P450.
Yajima K; Uno Y; Murayama N; Uehara S; Shimizu M; Nakamura C; Iwasaki K; Utoh M; Yamazaki H
Drug Metab Dispos; 2014 May; 42(5):867-71. PubMed ID: 24553381
[TBL] [Abstract][Full Text] [Related]
27. Interactions of pharmaceuticals and other xenobiotics on hepatic pregnane X receptor and cytochrome P450 3A signaling pathway in rainbow trout (Oncorhynchus mykiss).
Wassmur B; Gräns J; Kling P; Celander MC
Aquat Toxicol; 2010 Oct; 100(1):91-100. PubMed ID: 20719396
[TBL] [Abstract][Full Text] [Related]
28. Prediction of gestational age-dependent induction of in vivo hepatic CYP3A activity based on HepaRG cells and human hepatocytes.
Zhang Z; Farooq M; Prasad B; Grepper S; Unadkat JD
Drug Metab Dispos; 2015 Jun; 43(6):836-42. PubMed ID: 25802327
[TBL] [Abstract][Full Text] [Related]
29. In Vitro Approaches to Study Regulation of Hepatic Cytochrome P450 (CYP) 3A Expression by Paclitaxel and Rifampicin.
Ghose R; Mallick P; Taneja G; Chu C; Moorthy B
Methods Mol Biol; 2016; 1395():55-68. PubMed ID: 26910068
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of Methods to Assess CYP3A Induction Risk in Clinical Practice Using in Vitro Induction Parameters.
Tsutsui H; Kuramoto S; Ozeki K
Biol Pharm Bull; 2021; 44(3):338-349. PubMed ID: 33642543
[TBL] [Abstract][Full Text] [Related]
31. Identification and Optimization of Benzimidazole Sulfonamides as Orally Bioavailable Sphingosine 1-Phosphate Receptor 1 Antagonists with in Vivo Activity.
Hennessy EJ; Oza V; Adam A; Byth K; Castriotta L; Grewal G; Hamilton GA; Kamhi VM; Lewis P; Li D; Lyne P; Öster L; Rooney MT; Saeh JC; Sha L; Su Q; Wen S; Xue Y; Yang B
J Med Chem; 2015 Sep; 58(17):7057-75. PubMed ID: 26291341
[TBL] [Abstract][Full Text] [Related]
32. In vitro evaluation of hepatotoxic drugs in human hepatocytes from multiple donors: Identification of P450 activity as a potential risk factor for drug-induced liver injuries.
Utkarsh D; Loretz C; Li AP
Chem Biol Interact; 2016 Aug; 255():12-22. PubMed ID: 26718876
[TBL] [Abstract][Full Text] [Related]
33. Benzodiazepines medazepam and midazolam are activators of pregnane X receptor and weak inducers of CYP3A4: investigation in primary cultures of human hepatocytes and hepatocarcinoma cell lines.
Vrzal R; Kubesova K; Pavek P; Dvorak Z
Toxicol Lett; 2010 Mar; 193(2):183-8. PubMed ID: 20080160
[TBL] [Abstract][Full Text] [Related]
34. Risk assessment for drug-drug interaction caused by metabolism-based inhibition of CYP3A using automated in vitro assay systems and its application in the early drug discovery process.
Watanabe A; Nakamura K; Okudaira N; Okazaki O; Sudo K
Drug Metab Dispos; 2007 Jul; 35(7):1232-8. PubMed ID: 17392390
[TBL] [Abstract][Full Text] [Related]
35. Effects of pharmaceuticals on the expression of genes involved in detoxification in a carp primary hepatocyte model.
Corcoran J; Lange A; Winter MJ; Tyler CR
Environ Sci Technol; 2012 Jun; 46(11):6306-14. PubMed ID: 22559005
[TBL] [Abstract][Full Text] [Related]
36. A mechanistic physiologically based pharmacokinetic-enzyme turnover model involving both intestine and liver to predict CYP3A induction-mediated drug-drug interactions.
Guo H; Liu C; Li J; Zhang M; Hu M; Xu P; Liu L; Liu X
J Pharm Sci; 2013 Aug; 102(8):2819-36. PubMed ID: 23760985
[TBL] [Abstract][Full Text] [Related]
37. Temporal kinetics and concentration-response relationships for induction of CYP1A, CYP2B, and CYP3A in primary cultures of beagle dog hepatocytes.
Graham RA; Tyler LO; Krol WL; Silver IS; Webster LO; Clark P; Chen L; Banks T; LeCluyse EL
J Biochem Mol Toxicol; 2006; 20(2):69-78. PubMed ID: 16615094
[TBL] [Abstract][Full Text] [Related]
38. Use of 4β-hydroxycholesterol in animal and human plasma samples as a biomarker for CYP3A induction.
Xue YJ; Hoffmann M; Tong Z; Wu XI; Vallejo M; Melo B; Ye Y; Thomas M; Liu Y; Weiss D; Surapaneni S
Bioanalysis; 2016 Feb; 8(3):215-28. PubMed ID: 26805594
[TBL] [Abstract][Full Text] [Related]
39. Effects of mammalian CYP3A inducers on CYP3A-related enzyme activities in grass carp (Ctenopharyngodon idellus): Possible implications for the establishment of a fish CYP3A induction model.
Li D; Yang XL; Zhang SJ; Lin M; Yu WJ; Hu K
Comp Biochem Physiol C Toxicol Pharmacol; 2008 Jan; 147(1):17-29. PubMed ID: 17826359
[TBL] [Abstract][Full Text] [Related]
40. Cell isolation through whole-liver perfusion and preparation of hepatocytes for cytochrome p450 analysis.
Meheux SO
Methods Mol Biol; 2013; 1001():43-51. PubMed ID: 23494419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
